MLchartDataset catalogue

Totect

Term · Oncology and biomedicine · MLC-T-ONC-008782

A drug that contains the active ingredient dexrazoxane and is used to treat severe side effects caused by certain types of anticancer drugs. It is used to reduce heart damage in women who are receiving doxorubicin for breast cancer that has spread to other parts of the body. It is also used to treat the toxic effects of an anticancer drug that leaks from a vein into surrounding tissue and causes tissue damage. Totect is a type of cardioprotective agent, a type of chemoprotective agent, and a type of topoisomerase inhibitor.

Table 1. Record
IdentifierMLC-T-ONC-008782
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008782",
  "term": "Totect",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient dexrazoxane and is used to treat severe side effects caused by certain types of anticancer drugs. It is used to reduce heart damage in women who are receiving doxorubicin for breast cancer that has spread to other parts of the body. It is also used to treat the toxic effects of an anticancer drug that leaks from a vein into surrounding tissue and causes tissue damage. Totect is a type of cardioprotective agent, a type of chemoprotective agent, and a type of topoisomerase inhibitor.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/totect/"
}

Record 16,551 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.